VitVio
Vit Vio leverages AI and computer vision to enhance the efficiency of operating rooms, reducing administrative burdens and improving surgical outcomes. Their autonomous platform focuses on optimizing surgical workflows, tracking staff and equipment movements, and minimizing tool waste, which can significantly increase hospital profitability. With a commitment to safety and compliance, Vit Vio's technology integrates seamlessly with existing hospital systems, aiming to transform perioperative care and reduce staff burnout. Their innovative approach positions them as a leader in the surgical technology market, addressing the critical need for operational efficiency in healthcare.
VitVio
Vit Vio leverages AI and computer vision to enhance the efficiency of operating rooms, reducing administrative burdens and improving surgical outcomes. Their autonomous platform focuses on optimizing surgical workflows, tracking staff and equipment movements, and minimizing tool waste, which can significantly increase hospital profitability. With a commitment to safety and compliance, Vit Vio's technology integrates seamlessly with existing hospital systems, aiming to transform perioperative care and reduce staff burnout. Their innovative approach positions them as a leader in the surgical technology market, addressing the critical need for operational efficiency in healthcare.
TL;DR
What they do: AI/computer-vision platform that digitizes operating rooms to track staff, equipment, tool usage and surgery progress
Headquarters: Boston, Massachusetts, United States
Founders / leadership: Thomas Knox (Founder & CEO), Dr. Peter Rennert (Co‑founder & CTO), Maks Kozarzewski (Co‑founder & COO), Aleksander Pajewski (Co‑founder & CPO)
Funding (reported): $2M pre-seed announced Jan 2025 (total funding at that time reported $2M)
Employees: 17
Company Overview
Problem Domain
Perioperative efficiency, operating room workflow automation, surgical administrative burden reduction
Industry
Healthcare technology
Funding Track Record
$2,000,000
Announcement described participation from Bek Ventures, Tiny Supercomputer Investment Company and angel investors; pilot with Royal Orthopaedic Hospital.
Investor Signal
“Raised a $2M pre-seed led by venture firm LDV Capital with participation from other early-stage investors”